MHRA to cut 300 jobs amid financial pressures arising from Brexit
The UK’s medicines and healthcare products regulation agency (MHRA) is poised to make 300 members of staff redundant in the face of budget cuts that have raised questions over the agency’s future as a credible regulator.
The job cuts amount to 20% of the MHRA’s total workforce and are part of a transformation programme that will radically reshape how the agency operates. The MHRA has not revealed exactly where the cuts will hit but said it will be making savings in its operating costs, as well as redeploying and retraining staff in new areas of regulation and science.